[go: up one dir, main page]

Garaicoechea et al., 2014 - Google Patents

VHH Technology: A Potential Passive Immune Therapy to Control Rotavirus Infections in Human Infants

Garaicoechea et al., 2014

View PDF
Document ID
6749516833452796829
Author
Garaicoechea L
Vega C
Parreño V
Publication year
Publication venue
ROTAVIRUS INFECTIONS

External Links

Snippet

Until 1989 all IgG antibodies were thought to be composed of two heavy chains and two light chains. The two heavy chains are covalently linked by disulfide bonds. The heavy chains consist of one variable domain (VH) and three constant domains called CH1, CH2 and CH3 …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production

Similar Documents

Publication Publication Date Title
CN101878227B (en) Monomeric vhh domain derived from anti-VP6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections
Kovacs-Nolan et al. Egg yolk antibodies for passive immunity
US20120141503A1 (en) Heavy Chain and Domain Antibodies
US20200172582A1 (en) Lactobacillus acidophilus surface layer protein a (slpa) as a therapeutic agent for the treatment of inflammatory diseases
CN117126271B (en) Human neutralizing antibodies and bispecific antibodies targeting the envelope protein of fever with thrombocytopenia syndrome virus
CN119215164A (en) Anti-adrenomedullin (ADM) binders for treating or preventing disease symptoms
CN119684455A (en) Peptides
US20200317753A1 (en) Humanized Antibodies Against Enterovirus 71
Dubie et al. The potential application of avian egg antibodies with emphasis on immunotherapeutic and immunodiagnostic purpose
Feeney et al. The role of immunoglobulins from bovine colostrum and milk in human health promotion
Maffey et al. Controlling Rotavirus-associated diarrhea: Could single-domain antibody fragments make the difference?
CN102702349A (en) Bactrian camel VHH (variable domain of the heavy chain of HACbs) heavy-chain antibody for resisting foot-and-mouth disease AsiaI type viruses, preparation method and use thereof
Kovacs-Nolan et al. Passive immunization through avian egg antibodies
Garaicoechea et al. VHH Technology: A Potential Passive Immune Therapy to Control Rotavirus Infections in Human Infants
CN101965403A (en) A type Toxins, botulin neutralization composition and people's anti-A type Toxins, botulin antibody
US20090068176A1 (en) Human neutralizing antibodies aganst hemolytic uremic syndrome
CN112225804A (en) Nanobodies and uses thereof
CN112225805B (en) Nanobodies and uses thereof
Günaydın Host susceptibility to rotavirus infection and development of antibody-based immunotherapy
Kumar Antibody response to Rotavirus A and C in gilts and their piglets after prenatal Natural Planned Exposure
WO2024121125A1 (en) Single-domain antibodies to reduce the risk of cholera infection
CN112225801A (en) Nanobodies and uses thereof
CN112225800A (en) Nanobodies and uses thereof
CN112225802A (en) Nanobodies and uses thereof
CN112250761A (en) Nanobodies and uses thereof